Listed by the USPTO as GABEL, GAILENE
Tech Center 1600 • Art Units: 1641 1653 1671 1677 1678 1681
This examiner grants 76% of resolved cases
GABEL, GAILENE works in tech center 1600 and art unit 1641. The profile includes 939 resolved cases, an allowance rate of 75.6%, and a median of 1123 days to allowance. This combination reflects a substantial prosecution record with allowance occurring in a majority of the recorded matters, while the timing figure shows that successful prosecution may still require sustained pendency. Interviews carry a 44.7% lift, making them a particularly relevant consideration in applicant strategy.
The leading companies are Hoffmann-La Roche Inc., Wisconsin Alumni Research Foundation, and Texas Tech University System. The firm list includes DENTONS US LLP, Dickinson Wright PLLC - Washington DC, and FISH & RICHARDSON P.C. (TC). These organizations provide useful reference points for counsel evaluating experience in the examiner’s biotechnology-related docket. The interview result also supports preparing focused technical and claim discussions rather than treating interviews as a procedural formality.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18413506 | DELAY PROCESS TO PROVIDE TIMED CHEMISTRY TO LATERAL-FLOW IMMUNOASSAYS | Non-Final OA | The Government of the United States of America, as represented by the Secretary of the Navy |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.6% of resolved applications examined by Gailene Gabel were allowed (939 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +44.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Gailene Gabel took 1,123 days on average from filing to allowance.
Gailene Gabel examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
